Story · Public Health

Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation

2 outlets · first reported by PLOS Medicine 6d ago · latest 6d ago · 5 hours of coverage · 2 countries

Coverage, in order

  1. 6d ago
    first PLOS Medicine indie study
    Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation

    by Hallie Benjamin, Gregory Barnsley, Oliver J. Watson, Mark Jit Background COVID-19 vaccines played a critical role in reducing global health burden during the COVID-19 pandemic, but their rapid development required extraordinary effort. This study aims to evaluate their global…

  2. 6d ago
    The economic benefits of the covid vaccines may be double what we thought

    The covid-19 vaccines were costly to produce, but paid for themselves many times over Paul Christian Gordon / Alamy The covid-19 vaccines may have provided health and economic benefits worth up to $64.3 trillion in the first year alone – almost double an earlier estimate. Previously, researchers…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.